1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Systemic zoledronate treatment both prevents resorption of allograft bone and increases the retention of new formed bone during revascularization and remodelling
(
- Contribution to journal › Article
- 2004
-
Mark
Topical, single dose bisphosphonate treatment reduced bone resorption in a rat model for prosthetic loosening.
(
- Contribution to journal › Article
- 2003
-
Mark
A rat model for testing pharmacologic treatments of pressure-related bone loss
(
- Contribution to journal › Article
-
Mark
A combination of bisphosphonate and BMP additives in impacted bone allografts.
(
- Contribution to journal › Article
- 2002
-
Mark
Bone allografts pretreated with a bisphosphonate are not resorbed
(
- Contribution to journal › Article
-
Mark
Systemic alendronate prevents resorption of necrotic bone during revascularization. A bone chamber study in rats
(
- Contribution to journal › Article
-
Mark
Reduction of instability-induced bone resorption using bisphosphonates: high doses are needed in rats.
(
- Contribution to journal › Article